Ask AI

ClinicalThought

Share

Program Content

Activities

  • PI3K/AKT Inhibitors in mBC
    Novel Targeted Therapies for PIK3CA/AKT1/PTEN-Altered Metastatic Breast Cancer: Key Evidence and Real-world Insights to Optimize Patient Care
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 29, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd.